Similar articles

• Hormone replacement therapy and ovarian cancer risk--any news?

  Riman T. Riman T. Acta Obstet Gynecol Scand. 2007;86(9):1032-4. doi: 10.1080/00016340701505341. Acta Obstet Gynecol Scand. 2007. PMID: 17712640 No abstract available.
• Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.

  Glud E, Kjaer SK, Thomsen BL, Høgdall C, Christensen L, Høgdall E, Bock JE, Blaakaer J. Glud E, et al. Arch Intern Med. 2004 Nov 8;164(20):2253-9. doi: 10.1001/archinte.164.20.2253. Arch Intern Med. 2004. PMID: 15534163
• Does HRT promote ovarian cancer?

  [No authors listed] [No authors listed] Health News. 2001 May;7(5):8. Health News. 2001. PMID: 11851163 No abstract available.
• Estrogen-progestogen replacement therapy and ovarian cancer: an update.

  La Vecchia C. La Vecchia C. Eur J Cancer Prev. 2006 Dec;15(6):490-2. doi: 10.1097/01.cej.0000205026.14515.de. Eur J Cancer Prev. 2006. PMID: 17106327 Review.
• [Hormone therapies and ovarian cancer].

  Grenman S, Salmi T. Grenman S, et al. Duodecim. 2002;118(4):349-56. Duodecim. 2002. PMID: 12233039 Review. Finnish. No abstract available.